PATH EX

Medtech · Private

A fluidic platform device using inertial focusing to selectively remove bacteria and endotoxins from blood for sepsis treatment.

Claim this profile

Follows are private to you and power your alerts

Updated · pathex.co

Sector
Medtech
Total capital
$1.5M
Federal grants
$1.5M
2 awards · 2017–2018
Rank in peer group#236 of 477
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
7 pending · first 2024
Rank in peer group#155 of 477

Capital timeline

20172018FEDERAL ↑EQUITY ↓Cumulative $1.5M$225K$1.3M
20172018FEDERAL ↑EQUITY ↓Cumulative $1.5M$225K$1.3M

Latest events

  • Federal grantNSF · Phase II · SBIR Phase II: Rapid Blood Cleansing Device to Combat Infection$1.3M
  • Federal grantNSF · Phase I · STTR Phase I: Rapid Blood Cleansing Device to Combat Infection$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 477 peers

Line = median

Medtech · Device

  • Federal grants#236 · top 49%
  • Granted patents#155 · top 32%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Sinead MillerResearcherExecutive Officer, DirectorLinked by 1 patent · $1.5M in grants as PI
  • Alex WieselerExecutive Officer, DirectorNamed in SEC Form D filings
  • Ehsan JabbarzadehDirectorNamed in SEC Form D filings
  • Jeffrey BurbankDirectorNamed in SEC Form D filings
  • Sindead MillerExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 8
  • PendingDevice For The Capture And Removal Of Disease Material From FluidsUSPTOApplication 19009207
  • GrantedDevice For The Capture And Removal Of Disease Material From FluidsUSPTOUS 12,078,630
  • PendingMethod For The Capture And Isolation Of Disease Material From Flowing MatterUSPTOApplication 17224811
Show all 8 patent records
  • Device For The Capture And Removal Of Disease Material From FluidsSep 11, 2025 · Application 19009207Pending
  • Device For The Capture And Removal Of Disease Material From FluidsSep 3, 2024 · US 12,078,630Granted
  • Method For The Capture And Isolation Of Disease Material From Flowing MatterJul 22, 2021 · Application 17224811Pending
  • Method For The Capture And Isolation Of Disease Material From Flowing MatterApplication 62749911Pending
  • Method For The Capture And Isolation Of Disease Material From Flowing MatterApplication PCTUS2019057724Pending
  • Device For The Capture And Removal Of Disease Material From FluidsApplication 62614250Pending
  • Device For The Capture And Removal Of Disease Material From FluidsApplication 18749485Pending
  • Device For The Capture And Removal Of Disease Material From FluidsApplication PCTUS2019012403Pending
  • Path Ex, Inc.Shares a founder: Sinead Miller
  • Reflux CoSimilar federal contract value in Medtech · null in contracts
  • NeoGenesis Technologies LLCSimilar federal contract value in Medtech · null in contracts
  • OncoPatch, Inc.Similar federal contract value in Medtech · null in contracts
  • Okami Medical, Inc.Similar federal contract value in Medtech · null in contracts
  • CIRCA BIOSCIENCE LLCSimilar federal contract value in Medtech · null in contracts

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .